These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6677967)

  • 21. Synthesis and antimicrobial activity of 7 beta-[N-(arylmethyloxyimino) acetamido]cephalosporanic acid derivatives.
    Macchia M; Menchini E; Orlandini E; Rossello A; Broccali G; Visconti M
    Farmaco; 1995 Oct; 50(10):713-8. PubMed ID: 8590579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An in vitro characterization of cefditoren, a new oral cephalosporin.
    Felmingham D; Robbins MJ; Ghosh G; Bhogal H; Mehta MD; Leakey A; Clark S; Dencer CA; Ridgway GL; Grüneberg RN
    Drugs Exp Clin Res; 1994; 20(4):127-47. PubMed ID: 7813385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Frequency and antibiotic susceptibility of bacteria identified in urine].
    Sekhsokh Y; Chadli M; El Hamzaoui SA
    Med Mal Infect; 2008 Jun; 38(6):324-7. PubMed ID: 18395378
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibacterial activity of carbapenems against clinically isolated respiratory bacterial pathogens in Japan between 2003 and 2004.
    Watanabe A; Tokue Y; Kikuchi T; Gomi K; Aoki S; Satoh T; Fujimura S
    Int J Antimicrob Agents; 2005 Nov; 26(5):420-3. PubMed ID: 16216468
    [No Abstract]   [Full Text] [Related]  

  • 25. Clinical laboratory study of cephacetrile and cephalothin against bacteria recently isolated from clinical specimens.
    Isenberg HD; Painter BG; Sampson-Scherer J; Siegel M
    Arzneimittelforschung; 1974 Sep; 24(9b):1456-8. PubMed ID: 4479802
    [No Abstract]   [Full Text] [Related]  

  • 26. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Resistance to new types of cephalosporins in bacteria isolated from newborn infants].
    Krcméry V; Antal M; Havlík J
    Cesk Pediatr; 1985 Mar; 40(3):149-51. PubMed ID: 4005986
    [No Abstract]   [Full Text] [Related]  

  • 28. Worldwide assessment of the activity of cefotetan against clinical isolates.
    Turner PJ; Edwards JR
    J Chemother; 1989 Jul; 1(4 Suppl):97-8. PubMed ID: 16312321
    [No Abstract]   [Full Text] [Related]  

  • 29. Synthesis and antimicrobial activity of 7 beta-(S)- and 7 beta-[(R)-3-(methyleneaminoxy)-2-methylpropionamido]substituted cephalosporanic acid derivatives.
    Macchia M; Menchini E; Orlandini E; Rossello A; Broccali G; Visconti M
    Farmaco; 1996 Apr; 51(4):283-6. PubMed ID: 8645417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Comparative sensitivity of anaerobic germs to cephalosporins. Measurements of the minimum inibitory concentrations and minimum bactericidal concentrations].
    Mascellino MT; Bollino D; Rocco C; Latella C
    G Ital Chemioter; 1981; 28(1-2):1-4. PubMed ID: 7347701
    [No Abstract]   [Full Text] [Related]  

  • 31. [Microbiological study of a new derivative of cephalosporins C: cephalexine].
    Denis F; Brisou J; Boilleau Y; Besson J
    Bord Med; 1971 Apr; 4(4):1315-21. PubMed ID: 5562261
    [No Abstract]   [Full Text] [Related]  

  • 32. Sensitivity of bacterial isolates to cefoperazone.
    Peddie BA; Bishop V; Bailey RR
    Drugs; 1981; 22 Suppl 1():27-8. PubMed ID: 6456887
    [No Abstract]   [Full Text] [Related]  

  • 33. [In vitro antibacterial activity of eight third generation cephalosporins (author's transl)].
    Deforges L; Le Van Thoi J; Soussy CJ; Duval J
    Pathol Biol (Paris); 1982 Jun; 30(6):363-9. PubMed ID: 6810282
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibacterial activity in vitro of cefazolin].
    Carmenini G; Basso N; Terranova V; Nuzzolo L
    Minerva Med; 1975 Mar; 66(24):1169-72. PubMed ID: 1128791
    [No Abstract]   [Full Text] [Related]  

  • 35. [The modern view of cephalosporin antibiotics].
    Hejzlar M
    Cesk Pediatr; 1984 Apr; 39(4):218-20. PubMed ID: 6733798
    [No Abstract]   [Full Text] [Related]  

  • 36. [New 2d generation oral cephalosporins].
    Hejzlar M; Silarová J; St'astná L; Pellar T
    Cesk Pediatr; 1987 Mar; 42(3):152-4. PubMed ID: 3581270
    [No Abstract]   [Full Text] [Related]  

  • 37. Susceptibility of clinical isolates to cefoperazone.
    Bremner DA
    Drugs; 1981; 22 Suppl 1():29-31. PubMed ID: 6456888
    [No Abstract]   [Full Text] [Related]  

  • 38. Microbiology of oral cephalosporins.
    Cullmann W
    Antibiot Chemother (1971); 1995; 47():72-109. PubMed ID: 8554308
    [No Abstract]   [Full Text] [Related]  

  • 39. [Recently detected organisms from oral infectious diseases and their antimicrobial sensitivity].
    Tashiro T; Saitoh K; Siota T; Tezuka T; Suzuki N; Ohno K; Yoshida H; Michi K; Deguchi K
    Showa Shigakkai Zasshi; 1984 Sep; 4(1-2):40-7. PubMed ID: 6597502
    [No Abstract]   [Full Text] [Related]  

  • 40. [Microbiological, pharmacokinetic and clinical study of Cefacetril (Celospor)].
    Graber H; Arr M; Deutsch T; Ludwig E; Magyar T
    Orv Hetil; 1978 Apr; 119(17):1019-24. PubMed ID: 349466
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.